EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Comparative Efficacy of pHA130 Haemoadsorption Combined with Haemodialysis Versus Online Haemodiafiltration in Removing Protein-Bound and Middle-Molecular-Weight Uraemic Toxins: A Randomized Controlled Trial

Shaobin Yu iD, Huaihong Yuan, Xiaohong Xiong, Yalin Zhu, Ping Fu

Toxins · 2025

DOI: 10.3390/toxins17080392 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Toxins, 2025. Verfasst von Shaobin Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Hemodiafiltration, Renal Dialysis, Kidney Failure, Chronic, Uremic Toxins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Studies on Adsorption International Learning Initiative Global (SAILING) program, 1.3.5 project for disciplines of excellence from West China Hospital of Sichuan University, Sichuan Province Science Popularization Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein-bound uraemic toxins (PBUTs), such as indoxyl sulphate (IS) and p-cresyl sulphate (PCS), are poorly cleared by conventional haemodialysis (HD) or haemodiafiltration (HDF). Haemoadsorption combined with HD (HAHD) using the novel pHA130 cartridge may increase PBUT removal, and this trial aimed to compare its efficacy and safety with HDF in patients with end-stage renal disease (ESRD). In this single-centre, open-label trial, 30 maintenance HD patients were randomized (1:1:1) to HDF once every two weeks (HDF-q2w), HAHD once every two weeks (HAHD-q2w), or HAHD once weekly (HAHD-q1w) for 8 weeks, with the primary endpoint being the single-session reduction ratio (RR) of IS. The combined HAHD group (n = 20) demonstrated a significantly greater IS reduction than the HDF-q2w group (n = 10) (46.9% vs. 31.8%; p = 0.044) and superior PCS clearance (44.6% vs. 31.4%; p = 0.003). Both HAHD regimens significantly reduced predialysis IS levels at Week 8. Compared with HDF, weekly HAHD provided greater relief from pruritus and improved sleep quality, with comparable adverse events among groups. In conclusion, HAHD with the pHA130 cartridge is more effective than HDF for enhancing single-session PBUT removal and alleviating uraemic symptoms in patients with ESRD, with weekly application showing optimal symptomatic benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemodiafiltrationRenal DialysisKidney Failure, ChronicUremic ToxinsUremiaIndicanHumansMaleFemaleMiddle AgedAgedAdultTreatment OutcomeCresolsAdsorptionSulfuric Acid EstersToxins, Biological

Stichwörter der Autor:innen

haemoadsorption combined with haemodialysishaemodialysisindoxyl sulphatepHA130protein-bound uraemic toxins

Substanzen

Uremic ToxinsIndicanCresolsuremia middle molecule toxinsSulfuric Acid EstersToxins, Biological

Autor:innen und Institutionen

  • Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu 610041, China.

ORCID-Profile: Shaobin Yu

Förderung

  • Studies on Adsorption International Learning Initiative Global (SAILING) program
  • 1.3.5 project for disciplines of excellence from West China Hospital of Sichuan University
  • Sichuan Province Science Popularization Training Program

Zitieren

APA

Yu, S., Yuan, H., Xiong, X., Zhu, Y., & Fu, P. (2025). Comparative Efficacy of pHA130 Haemoadsorption Combined with Haemodialysis Versus Online Haemodiafiltration in Removing Protein-Bound and Middle-Molecular-Weight Uraemic Toxins: A Randomized Controlled Trial. Toxins. https://doi.org/10.3390/toxins17080392

Vancouver

Yu S, Yuan H, Xiong X, Zhu Y, Fu P. Comparative Efficacy of pHA130 Haemoadsorption Combined with Haemodialysis Versus Online Haemodiafiltration in Removing Protein-Bound and Middle-Molecular-Weight Uraemic Toxins: A Randomized Controlled Trial. Toxins. 2025. doi:10.3390/toxins17080392

BibTeX
@article{Yu2025,
  author = {Yu, Shaobin and Yuan, Huaihong and Xiong, Xiaohong and Zhu, Yalin and Fu, Ping},
  title = {Comparative Efficacy of pHA130 Haemoadsorption Combined with Haemodialysis Versus Online Haemodiafiltration in Removing Protein-Bound and Middle-Molecular-Weight Uraemic Toxins: A Randomized Controlled Trial},
  journal = {Toxins},
  year = {2025},
  doi = {10.3390/toxins17080392}
}
Kostenlos starten →